English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 27 October 2022, 18:04 HKT/SGT
Share:
    

Source: Eminence Business Media
Watch the Biggest T10 Indian Pharma Championship on VOOT live

MUMBAI, INDIA, Oct 27, 2022 - (ACN Newswire) - Keeping the spirit of cricket in mind, Eminence Business Media is proud to announce T10 Indian Pharma Champions Trophy 2022 scheduled for December 1-7, 2022, in Mumbai. Managing Director of Eminence Business Media, Ms. Guneet Kaur Hayer, believes that cricket is not just a sport for many; it is an emotion and as a company they want people to take a short rejuvenating break from their tiring work, and to do something that works for their physical health, mental health, and fitness at par. She also said it is every company's responsibility to keep their employees healthy, fit, engaged, appreciated and happy with their jobs.


For the first time ever, a cricket league of such a high stature has been announce exclusively for the Pharmaceutical Industry that would make an enduring impact on people's lives. It provides great entertainment, teaches important skills; physical, mental, and social.

What's in It for the Pharma Teams?
1. Winning prize money for up to INR 25 Lakhs.
2. Live streaming gives that celebrity vibe to show your talent on the screen to 20 million viewers.
3. Four-wheeler, two wheelers and several other remunerative awards for Man of the Series, Man of the Matches, Purple Hat, Orange Hat Winners and more.
4. Win gadgets like Laptops, mobiles and more.
5. Best of all is the joy of playing cricket and winning the championship.
6. Support NGO by participating, or partnering, where in part percentage will go in donation to them.

What's in It for the Sponsors?
1. Exclusive Brand Positioning & Visibility.
2. Exclusive marketing
3. Live streaming on VOOT across the nation.
4. On air campaigns in multiple cities.
5. Network and enhance your market reach.
6. Pre- scheduled meetings.
7. Support NGO by participating, or partnering, where in part percentage will go in donation to them.

Topic: Press release summary
Source: Eminence Business Media


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
A New Benchmark for Specialized Technology Stocks in Hong Kong! CiDi's Listing Marks a New Chapter in Commercial Intelligent Driving  
Dec 19, 2025 10:30 HKT/SGT
Air T, Inc. Announces Closing of Regional Express Acquisition  
Dec 19, 2025 06:10 HKT/SGT
MHI Participates in Demonstration Testing of Vehicle-Infrastructure Integration System for Autonomous Buses in Shimotsuke City  
Friday, December 19, 2025 2:24:00 AM
NEC and emaratech Collaborate on Biometric Smart Gates Supporting UAE Airport Operations  
Friday, December 19, 2025 2:06:00 AM
Fujitsu to showcase mobility and physical AI tech at CES 2026  
Friday, December 19, 2025 1:42:00 AM
Kirin and Fujitsu elucidate a novel gut-brain axis mechanism of citicoline for the first time worldwide through AI-based analysis and experimental validation leveraging drug discovery DX technology  
Friday, December 19, 2025 1:06:00 AM
TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Released Their Fourth Collaborative Musical Work with Sound Wellness Lab (Della): "Precious Metal Orchestra - A Musical Voyage through the Sound of Precious Metals for Christmas" now available for streaming.  
Thursday, December 18, 2025 9:00:00 PM
Focus Graphite Announces Final Results From 2022 Drill Program at Lac Tetepisca; West Limb Extends Mineralized Strike to 8 KM  
Dec 18, 2025 18:09 HKT/SGT
Spritzer MerryLand Returns This Year-End, Bringing Magical Festive Cheer to Taiping  
Thursday, December 18, 2025 5:44:00 PM
PropertyGuru Asia Real Estate Summit spotlights PropertyGuru Week 2025 with conversations on 'Trusted Marketplaces and Thriving Communities'  
Dec 18, 2025 09:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575